Case report highlights alpha-fetoprotein's potential as a biomarker in CA19-9-negative PDAC patients, suggesting new diagnostic avenues.
This case demonstrates that AFP may be a potential biomarker for PDAC, especially in the CA19-9-negative PDAC patient.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: